+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06779149

Comparing Cognitive Behavioral Therapy and Lemborexant Medication for Treating Different Types of Chronic Insomnia in Adults

Led by Laval University · Updated on 2025-04-09

90

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of Cognitive Behavioral Therapy for Insomnia CBT-I and the medication lemborexant compared to a placebo in adults with insomnia disorder who also have symptoms of anxiety or depression. The study aims to see how these treatments affect sleep and mental health, and whether different types of insomnia, based on sleep duration, influence treatment outcomes. This is an interventional study involving random assignment to treatment groups. Participants will be randomly assigned to one of three groups CBT-I therapy, lemborexant medication, or placebo medication. CBT-I involves six therapy sessions over eight weeks, with weekly sessions at first and then biweekly. Those in the medication groups will take 5 to 10 mg of lemborexant or a matching placebo at bedtime for eight weeks, with six consultation visits to monitor response and side effects. Dose adjustment from 5 mg to 10 mg may occur after the first week if needed. Participants will undergo assessments at baseline, after treatment, and at six months follow-up. They will complete sleep diaries nightly before, during, and after treatment to track sleep onset, wake time, total sleep time, and sleep efficiency. Researchers will also measure insomnia severity, depressive and anxiety symptoms, mental well-being, fatigue, functional impact of insomnia, and sleep-related beliefs. The study includes safety monitoring and aims to evaluate outcomes over several months.

CONDITIONS

Brief Title

Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia

Research Team

M

Manon Lamy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here